Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Pfizer recalls certain lots of blood-pressure drug Accupril

By Brian Buntz | April 25, 2022

Pfizer logoPfizer (NYSE:PFE) has announced a voluntary recall of five lots of Accupril (Quinapril HCl) tablets owing to elevated levels of the nitrosamine N-nitroso-quinapril. 

Accupril, an angiotensin-converting enzyme (ACE) inhibitor, is indicated for treating hypertension. FDA has also approved its use as an adjunctive therapy for treating heart failure. 

N-nitroso-quinapril, which can be frequently found in water and some foods in low levels, may pose a cancer risk in higher levels. 

Pfizer concluded that the nitrosamine in certain Accupril lots was above the acceptable daily intake value.  

The company has not observed adverse event reports related to the elevated levels of N-nitroso-quinapril in some lots. 

Pfizer reports that the affected lots were distributed in the U.S. and Puerto Rico from December 2019 to April 2022.

In recent years, FDA has exerted pressure on the pharmaceutical industry to test potentially hundreds of medications for nitrosamine. 

Based on FDA’s requested review, Pfizer has identified issues with Chantix, Metformin, Zantac and Accuretic, among others.

The Novartis subsidiary Sandoz recently recalled 13 lots of orphenadrine citrate after detection of nitrosamine impurities. 

Tell Us What You Think! Cancel reply

Related Articles Read More >

FDA clears antibiotic-embedded hernia mesh for fighting implant infections
Roche/Novartis
Roche finalizes repurchase of shares from Novartis
Joe Biden
President Biden unveils initiative to boost COVID-19 vaccination numbers
coronavirus COVID-19 Pfizer
7 core strategies in Biden’s battle against COVID-19

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards